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Abstract
The Graduated Recovery Intervention Program (GRIP) is a new individual cognitive-behavioral
therapy program designed to facilitate functional recovery in people who have experienced an
initial episode of psychosis. The purpose of this study was to evaluate the feasibility and
tolerability of the GRIP intervention, and to compare the effectiveness of GRIP versus treatment
as usual (TAU) for improving specific clinical and psychosocial outcomes. Forty-six individuals
with first episode psychosis were randomized to GRIP + TAU or TAU alone. Primary outcomes
focused on social and role functioning, and quality of life. Secondary outcomes included psychotic
symptoms, depression, substance use, social support, attitudes toward medications, well-being,
and hospitalizations. The results indicate that GRIP was well-tolerated, as evidenced by good
attendance and low drop-out rates, and well-received (based on positive feedback from
participants). Although the majority of mixed-model analyses were not statistically significant,
examination of within-group changes and effect sizes suggest an advantage for GRIP over TAU in
improving functional outcomes. These advantages and the fact that the GRIP intervention
demonstrated feasibility and tolerability suggest that this intervention is worthy of further
investigation.
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1. Introduction
There is emerging evidence that sustained and targeted intervention early in the course of
psychotic disorders is essential in order to facilitate recovery from a first episode, reduce the
risk of relapse and re-hospitalization, and minimize psychosocial deterioration (Birchwood,
Todd, & Jackson, 1998; Malla, Norman, & Joober, 2005). One approach to early
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intervention is via individual therapy (J. Addington & Gleeson, 2005). In general, individual
therapy has been shown to reduce suicidal ideation and hopelessness (Power et al., 2003),
substance use (Kavanagh et al., 2004), positive symptoms (Uzenoff, Perkins, Hamer,
Wiesen, & Penn, 2008), relapse rates (Gleeson et al., 2009), and increase activity levels
(Fowler et al., 2009), although there are exceptions (J Edwards et al., 2006; Nicholas
Tarrier, Haddock, Lewis, Drake, & Gregg, 2006). Such individual therapy approaches may
be more effective later rather than earlier in the course of recovery (i.e., when clients are
more stable) (C. Jackson et al., 2009; Lewis et al., 2002; Nick Tarrier et al., 2004), and it
remains unclear whether group treatment confers greater benefits than individual treatments
(Lecomte et al., 2008; Saksa, Cohen, Srihari, & Woods, 2009). Overall, individual therapy
appears to have promise as a front line intervention for first episode psychosis (Haddock &
Lewis, 2005; Harvey, Lepage, & Malla, 2007; Penn, Waldheter, Perkins, Mueser, &
Lieberman, 2005).
Despite the encouraging findings for individual therapy for first episode psychosis, there
have been no controlled evaluations of this treatment approach in the United States. In
addition, the targets of extant individual therapy approaches for an early psychosis
population have often been narrowly defined, emphasizing only one or two areas of concern
for individuals recovering from a first episode, such as symptoms (Lewis et al., 2002) or
substance use (J. Edwards, Hinton, Elkins, & Anthanasopoulos, 2003), and not functional
recovery (for an exception, see (Fowler et al., 2009). Thus, the impact of individual therapy
on first episode psychosis seems to be more domain-specific than broad-based.
To address these unmet needs, we developed the Graduated Recovery Intervention Program
(GRIP). GRIP is a comprehensive, flexible, modular-based cognitive-behavioral therapy
program that aims to enhance illness management and facilitate functional recovery (i.e.
social skill, role and community functioning) following a first episode of psychosis. The
GRIP program places an emphasis on personal goal pursuit to foster optimism and self-
esteem, targets malleable factors that may enhance recovery such as residual symptoms and
substance use, and enlists external social support to maximize therapeutic gains and
engagement.
Following a thorough treatment development period (i.e., writing of the manual; obtaining
feedback from clients, clinicians, and researchers; revising the manual) (Waldheter et al.,
2008), we conducted an open-trial of GRIP with 10 individuals with first episode psychosis.
Qualitative feedback and ratings indicated that GRIP was well-received by clients and
clinicians, and it was associated with reduced positive symptoms at post-treatment
(Waldheter et al., 2008). Reductions in symptoms and improvements in social functioning
and goal attainment were especially pronounced for treatment completers (i.e. clients who
received at least 12 sessions), underscoring the importance of treatment engagement. These
findings led to manual revisions for developing better strategies for retention (e.g. by
offering GRIP on a more flexible basis) and adding content on managing grief and loss
following an initial psychotic episode.
Based on the promising findings of the open trial, we designed a preliminary, small-scale
randomized controlled trial (RCT), comparing GRIP + Treatment as Usual (TAU) versus
TAU alone. TAU was provided in the context of a specialty first episode program in Chapel
Hill, NC, Outreach and Support Intervention Services (OASIS). The primary purpose of this
trial was to examine the feasibility and tolerability of GRIP. The secondary purpose was to
obtain specific treatment parameters (e.g. effect sizes and variances, with confidence
intervals) that may inform the implementation of a larger, more definitive RCT (although
extrapolating effect sizes from pilot to large scale randomized controlled trials need to be
done cautiously) (Kraemer, Mintz, Noda, Tinklenberg, & Yesavage, 2006). This approach is
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consistent with pilot interventions early in development (Mueser & Drake, 2005). We
expected that GRIP would be well-tolerated, as measured by good attendance and low drop-
out rates, and received (based on feedback from clients), and that it would be associated with
a greater reduction in symptoms and substance use, improvement in functioning, and lower
hospitalization rates than TAU alone.
2. Methods
2.1. Participants
The participants in this RCT comparing GRIP + TAU to TAU alone were recruited from the
UNC OASIS program (described below), with the exception of two individuals who were
recruited from another UNC outpatient program (the Schizophrenia Treatment and
Evaluation Program; STEP). Study participants were individuals with early psychosis
meeting the following inclusion criteria: a) 18 years of age or older; b) current or past
diagnosis of schizophrenia, schizophreniform disorder, or schizoaffective disorder according
to the SCID-P, and; c) within the first three years of treatment for psychosis. Exclusion
criteria included: a) current dependence on alcohol or drugs; b) history of mental retardation
(i.e. IQ<70), and c) history of significant neurological disorder.
2.2. Treatment Groups
2.2.1. GRIP—The development of GRIP has been described in a recent report (Waldheter
et al., 2008). GRIP is provided on an individual, weekly basis for up to 36 sessions, and
comprises four phases: (1) engagement and wellness management; (2) substance use; (3)
persistent symptoms; and (4) functional recovery. The first 12 sessions of GRIP (i.e.,
psychoeducation, processing the illness, goal setting, illness management, relapse
prevention, and psychoeducation about substances) are relatively standardized with respect
to treatment foci. During the first phase, the client is asked to identify an “indigenous
supporter” (a friend, relative, or support person who they see on a regular basis) who can
assist the client with homework and goal pursuit (Tauber, Wallace, & Lecomte, 2000). The
clinician is instructed to communicate periodically (at least monthly) with indigenous
supporters to track client progress and troubleshoot potential problems and issues.
After 12 sessions have been completed, progress is evaluated via reviewing goal attainment
and the client and therapist collaboratively determine whether additional treatment is
necessary (i.e., in the case of incomplete goals, identification of new goals, or the
persistence or emergence of problem areas or symptoms) and if so, which module(s) are
pursued. The remaining sessions are flexible and individually tailored to the needs of the
client. Therapists are encouraged to follow the prescribed order of treatment phases;
however, pressing client concerns are always prioritized, regardless of phase. Based on an
individual assessment, clients can receive assistance with current substance use problems
(module two), persistent positive and/or negative symptoms (module three), and functional
impairments (module four). Intervention techniques include psychoeducation, cognitive
behavioral therapy (CBT) (i.e., for addressing residual symptoms), motivational
interviewing (i.e. for substance use, if necessary), and social skills training (to enhance
social functioning).
2.2.2 TAU—The OASIS program is a comprehensive, multi-element clinic for the
treatment of early psychosis. The clinic is operated by the UNC Health Care System, a not-
for-profit integrated healthcare system, owned by the State of North Carolina and based in
Chapel Hill, NC. Consistent with the program’s emphasis on community outreach and
accessibility, the clinic is located separate from the primary hospital complex in an easily
accessible office suite.
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OASIS serves adolescents and young adults aged 16–36 who have been treated for
psychosis (i.e. have been taking antipsychotic medications) for no more than three years, as
well as previously unmedicated individuals who have been ill for up to 5 years. Referrals to
OASIS come from several sources, primary among which are the inpatient and emergency
treatment services of the UNC Hospital System. Additional referral sources include the
UNC counseling center, UNC STEP, family members, and community mental health
providers.
Every client is assigned a primary clinician (a licensed or licensed eligible social worker)
who provides clinical services and case management based on individual need. Interventions
range from engagement techniques (i.e. making phone calls to engage reluctant or
withdrawn clients) to various aspects of case management, to providing individual
supportive and cognitive-behavioral therapy. Services are frequently provided in the
community or at the client’s home in addition to in the office. Each client also receives
psychiatric assessment and medication management from a psychiatrist. In addition, family
members are encouraged to attend either single or multi-family treatment. OASIS offers
time-limited groups lasting for 8–12 weeks depending on client interest and need. Topics
include psychoeducation, healthy lifestyle habits, stress management, substance abuse and
social skills training. Finally, a certified substance abuse counselor provides substance abuse
assessment, individual therapy and leads a group following the integrated dual diagnosis
modality of treatment. Clients’ utilization of these services depends on their need and
interest, and treatment team recommendations.
2.2.3 Therapists and Fidelity—Three therapists provided GRIP: two social workers
(each seeing 10 clients) and one clinical psychologist (the PI, who provided treatment to
three GRIP clients). The social workers were trained over approximately a one month period
via didactic presentations, required readings, role plays, and listening to therapy tapes from
the open trial. The PI (who served as clinical supervisor) further evaluated competence via
listening to every therapy session and providing detailed feedback/comments to therapists
during weekly supervision meetings. Audiotaped therapy sessions were later rated by either
the PI or Co-I (Kim T. Mueser, Ph.D.) for fidelity to the GRIP manual (NOTE: the fidelity
manual was developed following the open trial). Twenty two percent of the total sessions
were rated for treatment fidelity. Overall, the therapists received overall mean quality ratings
from 3.78 to 4.21 (range = 1–5), indicating good to very good ratings, which reflect how
well the rater believes the therapist implemented the prescribed techniques, and considering
issues of therapist demeanor, style and skill.
3.0 Measures
Participants were assessed at baseline, post-treatment, and 3-month follow-up on measures
of functioning (addressed throughout GRIP, but predominantly in Module #4), psychiatric
symptoms (addressed in Modules #1 and #3), substance use (addressed in Modules #1 and
#2), mood (which we expect to improve as illness management and goal achievement
occurs), social support (addressed throughout GRIP, but predominantly in Module #4),
attitudes toward medications (addressed in Module #1), well-being (which is a more distal
outcome that we expect to improve after goal achievement and functional recovery occur),
and hospitalizations.
Below, the battery is summarized in terms of screening measures (prior to baseline), and
primary and secondary outcomes.
Penn et al. Page 4














Diagnosis was verified by the Structured Clinical Interview for DSM-IV (SCID-P) and a
chart review.
IQ was estimated using the Wechsler Abbreviated Scales for Intelligence (WASI) (The
Psychological Corporation, 1999), which is comprised of Matrix Reasoning, Vocabulary,
Similarities, and the Block Design subtests.
3.2 Primary Outcomes
The primary outcomes for this study focused on functional outcomes and included quality of
life, community functioning, and social skill.
Quality of life was measured using the Quality of Life Scale (QLS) (Heinrichs, Hanlon, &
Carpenter, 1984). This assessment is a semi-structured interview comprising 21 items rated
on a scale from 0 to 6. Lower scores reflect greater impairments in functioning. The QLS
generates four subscales (Interpersonal Relations, Instrumental Role, Intrapsychic
Foundations, and Common Objects and Activities). In the current study, we did not include
the last two subscales, but rather focused on the Interpersonal Relations subscale (8 items)
and Instrumental Role subscale (4 items), due to the emphasis of the treatment study on
functional recovery.
Community functioning was measured with the Role Functioning Scale (RFS) (Goodman,
Sewell, Cooley, & Leavitt, 1993) and the Multnomah Community Ability Scale (MCAS)
(Dickerson, Origoni, Pater, Friedman, & Kordonski, 2003). Ratings on the RFS were based
on information obtained from interviews conducted with the participant’s significant other
and were based on the participant's functioning in the week prior to the evaluation.
Participants were rated on a 1–7 scale (1 = very minimal level of role functioning, 7 =
optimal level of role functioning) on the following areas: Work productivity, independent
living, immediate social network, and extended social network. Interviewers achieved inter-
rater reliability of .70 or higher (ICCs) for all subscales. A total RFS score was computed by
summing across all subscales.
Information used for MCAS ratings was obtained via chart review and integration of all
available study data (i.e. other assessments). From these sources, we were able to compute a
social competence subscale (social acceptability, social interest, and social effectiveness
items) and a modified adjustment to living subscale (independence of daily living and
acceptance of illness items). Inter-rater reliability for both subscales was adequate (ICCs ≥ .
70).
Social skill was evaluated via the Social Skills Performance Assessment (Patterson,
Moscona, McKibbin, Davidson, & Jeste, 2001). The SSPA consists of two, 3-minute role
play conversations with a research confederate on pre-determined topics (e.g. meeting a new
neighbor and requesting repairs from a landlord). SSPA performance was tape-recorded and
scored by two coders, trained to reliability (ICCs ≥ .70), and blind to treatment condition
and assessment status (i.e. pre, post-test, 3-month follow-up). Although ratings were made
on a variety of social skill indices (e.g. speech fluency and clarity), we focused on overall
social appropriateness across the two scenes so as to reduce the number of variables for
subsequent data analyses.
3.3 Secondary Outcomes
Interviewer-rated secondary outcomes measures included the three subscales (i.e., positive,
negative, and general symptoms) and total score from the PANSS (Kay, Opler, &
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Lindenmayer, 1988) and the Calgary Depression Scale for Schizophrenia (CDSS) (D.
Addington, Addington, & Maticka-Tyndale, 1993). Raters were blind to treatment condition
and were trained using a series of “gold standard” videotapes (i.e., ICCs ≥ .80).
Additional secondary outcomes included well-being, as measured by the environmental
mastery (alpha =.89) and the purpose in life (alpha=.83) subscales from the Scales of
Psychological Well Being (Ryff, 1989) (Note: These subscales were combined into a single
scale as they were highly correlated (r=.74, p<.01)), social support, as measured by the
Multidimensional Scale of Perceived Social Support (MSPSS) (alpha=.91) (Zimet, Powell,
Farley, & Werkman, 1990), alcohol and illicit drug use as assessed with the Alcohol Use
Scale (AUS) and Drug Use Scale (DUS), respectively (Drake, Mueser, & McHugo, 1996),
and attitudes toward medications as measured by the Brief Evaluation of Medication
Influence and Beliefs (BEMIB) (alpha=.72) (Dolder et al., 2004). The BEMIB has been
shown to reliably and accurately identify individuals who are likely to be non-adherent with
prescribed medication. Frequency and duration of readmission to the hospital was measured
using participant self-report that was verified by chart review. Both the number and duration
of hospitalizations were recorded.
Finally, we asked clients (who received GRIP only) and their study therapists to rate their
progress in achieving goals on a “1” (no progress) to “5” (goal was achieved) likert scale, as
well as to complete a brief questionnaire to provide feedback on GRIP following completion
of the program (Waldheter et al., 2008).
4.0 Procedures
Clinical interviews evaluating psychiatric symptoms (PANSS), quality of life (QLS),
substance use (AUS/DUS) and depression (CDSS) were conducted by assessors (a licensed
clinical social worker and a licensed clinical psychologist) blind to treatment group. As a
check on rater blindness, the clinical assessors were asked to guess participants’ group
assignment. The primary interviewer (social worker) correctly guessed group assignment for
54.3% of the participants, while the back-up interviewer (clinical psychologist) guessed
correctly for 43.5% of the participants. These guesses appear to be within chance.
All recruitment procedures and self-report evaluations were conducted by two research
assistants (i.e. a full-time staff person and a doctoral student in clinical psychology) who
were not blind to treatment condition. These RAs were supervised weekly by the PI (DP)
and managed the day-to-day running of the study, in addition to administering the self-report
study measures (and rating client functioning, based on chart review).
The majority of participants in this study were referred by OASIS clinicians, with whom we
met weekly during team meetings. Once potential participants were identified by their
primary clinician and agreed to be contacted, they were screened over the phone in terms of
general eligibility and interest in the study. Following the phone screen, potential
participants were then formally interviewed to assess eligibility and obtain consent, and if
they were deemed eligible, the participants were assessed on the outcome measures.
Participants who completed the screening and baseline interviews were randomly assigned
to one of two conditions: 1) GRIP + TAU or 2) TAU alone. Randomization was stratified by
gender to ensure equal numbers across conditions using a computer randomization
generator. Participants were assessed at baseline, post-treatment, and at 3-month follow-up.
Each participant who received TAU alone was yoked to a participant receiving GRIP, and
post-test and follow-up assessments for each yoked pair were determined by the timeline of
treatment completion for the GRIP participant.
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5.1 Data Analysis Overview
Statistical analyses were conducted on the full, intent-to-treat, sample using mixed effects
linear modeling to compare the two groups over time on the outcome variables listed above,
with baseline performance as a covariate. The statistical analysis plans in the original grant
application were to fit a random coefficient model; however, with only two post-baseline
visits (GRIP versus TAU), we decided to treat the visit variable categorically and fit a more
standard mixed model approach to repeated measures using an unstructured covariance
structure among the repeated measures. This did not alter the results. The models included
treatment, assessment point, treatment-by-assessment interaction, and baseline value of the
response variable. Denominator degrees of freedom were calculated using the Kenward-
Roger method (Kenward & Roger, 1997). Because we did not control for multiple
comparisons, and we had multiple response variables, any treatment differences found were
to be considered suggestive only. In addition, we computed within group effect sizes for all
variables. These analyses should be considered exploratory given the small sample size
associated with interventions at this stage of treatment development (Mueser & Drake,
2005), which can result in large standard errors (Kraemer et al., 2006)
We conclude the data analysis section with a summary of participants’ goal attainment, as
well as feedback on GRIP, both of which are broken down by treatment completion status
(i.e. treatment completers versus non-completers).
5.2 Preliminary analyses
During the active recruitment phase, 144 individuals were referred for the study (see Figure
1 for consort diagram). Fifty-six individuals were ineligible to participate, and 41
individuals refused to participate. Forty-seven individuals were screened, 46 of whom were
then subsequently randomized (GRIP=23, TAU=23). In each treatment condition, 1
participant dropped out before the end of the study (i.e. did not complete post-test), and an
additional participant dropped out before the 3-month follow-up assessment. Overall, 96%
of the sample (N=44) completed post-test, and 91% of all participants (N=42) completed the
3-month assessment, with no differential rates of attrition between GRIP and TAU.
In regard to tolerability, GRIP participants (N=23) attended a mean of 19 sessions
(SD=12.1, range=4–36), and 61% (N=14) of GRIP participants were considered to be
treatment completers (i.e. attended at least 12 sessions, corresponding to Phase I of GRIP).
Treatment completers attended a mean of 26 sessions (SD=9.7, range=12–36). Non-
completers attended a mean of 7 sessions (SD=2.5, range=4–11). Reasons for receiving less
than 12 sessions included: 1) participant moved (n=3); 2) suicide (n=1); 3) inconsistent
attendance (n=1); 4) participant did not want to participate in therapy anymore (n=3) and 5)
unknown (n=1). Treatment completers and non-completers did not differ on any baseline
outcome variables.
Demographic characteristics of the study participants are summarized in Table 1. Sixty-one
percent of participants in each group (GRIP + TAU and TAU) were male. Ethnic
composition of the total sample was 63% (N=29) Caucasian, 28% (N=13) African-
American, and 9% (N=4) ‘other’. Participants who identified ethnically as ‘other’ listed the
following ethnicities: African (N=1), Filipino (N=1), Cherokee Indian (N=1), and Hispanic
(N=1). Hispanic enrollment included 3 males, one of whom identified as Caucasian, one as
African-American, and one as ‘other’ (Hispanic). The average age of all participants was 22
years old (SD=3.36, range =18–35) (with GRIP participants being significantly older than
TAU participants), 94% were never married, and 93% had completed high school. The most
common diagnosis was schizophrenia (54%, N=25), followed by schizophreniform disorder
Penn et al. Page 7













(28%, N=13), and schizoaffective disorder (17%, N=8). The mean duration of time between
onset of first sign or symptom of illness and date of first treatment (duration of untreated
illness; DUI) was 23 months (SD=26.52), and the mean duration of time between onset of
full syndrome and date of first treatment (duration of untreated psychosis; DUP) was 4
months (SD=8.76).
Ninety-eight percent (N=45) of participants were prescribed at least one atypical
antipsychotic medication over the course of the study, and 11% (N=5) of participants were
prescribed both atypical and typical antipsychotic medications. Seventy-six percent (N=35)
were prescribed an additional psychotropic medication in addition to an antipsychotic
medication. One participant refused all medications for the duration of the study.
5.3 Primary analyses
The majority of the mixed model analyses were not statistically significant (in terms of
group or group X time interactions). However, participants who received GRIP showed
greater improvement in work functioning on the RFS at follow-up relative to TAU, while
TAU participants showed greater improvement in perceived social support at follow-up
relative to those who received GRIP. In addition, there was a trend (p < .10) in favor of
GRIP participants showing a greater reduction in PANSS general symptoms at follow-up
relative to those in TAU, and for TAU participants showing a greater reduction in
depression (CDSS) through follow-up (and see section 5.4 for discussion of within-group
change) (see Tables 2 and 3).
5.4. Supplemental analyses
In addition to the foregoing, we examined within-group changes and effect sizes. Table 2
summarizes the results for the functional outcomes. In general, effect sizes for GRIP both at
post-test and at 3-month follow up are larger than those for TAU on the RFS subscales,
QOL social subscale, and the MCAS social competence scale. Significant within group
change was observed for GRIP on the RFS-extended social network and total, and the
MCAS social competence scale (baseline to post-test; baseline to follow-up). Within group
change on the RFS-immediate social network and QOL-social approached statistical
significance (baseline to follow-up). Effect sizes were in the medium-large range.
The only functional variable to demonstrate a significant change for the TAU group was
RFS-extended social network (baseline to follow-up). Within group change on the RFS-
Total approached statistical significance (baseline to follow-up). These results suggest that
GRIP might have a greater impact on functional outcomes than TAU, although data from
two of the variables (i.e., RFS and MCAS) were obtained from non-blinded raters and we
did not directly compare effect sizes across conditions.
Table 3 summarizes the results for the other study outcomes. Both groups demonstrated a
significant reduction in depression from baseline through follow-up on the CDSS. The TAU
group reported improved social support through follow-up and better attitudes toward
medications through post-treatment. The GRIP group had higher effect sizes through follow-
up on the PANSS than the TAU group, but within group change was not statistically
significant. Finally, the GRIP group demonstrated an unexpected worsening of alcohol use
from baseline to follow-up.
Table 4 summarizes the results for the hospitalization data. The TAU group had twice as
many hospitalizations and was hospitalized for more days than the GRIP group. It should be
noted, however, that the latter finding was greatly influenced by one TAU participant who
had been hospitalized for 100 days.
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Of the 22 participants in the GRIP condition who completed post-test, clients set an average
of 3.18 goals (SD 1.37, range 1–6). Fifty-eight percent of all personal goals were rated by
participants at post-test as “very close to being achieved” or “achieved.” Further analyses
revealed a difference between GRIP completers and non-completers. While treatment
completers collectively rated 65% of their personal goals at post-test as “very close to being
achieved” or “achieved,” only 43% of the treatment non-completers’ goals received those
same ratings.
Therapists rated 51% of client goals as being “very close to being achieved” or “achieved”
by post-test. Similar to the client ratings made by treatment completers, therapists rated 65%
of treatment completers’ goals as “very close to being achieved” or “achieved.” However
therapists assessed that only 19% of non-completers’ goals met this same standard.
5.6. Qualitative feedback
Table 5 summarizes the qualitative ratings from GRIP participants. Overall, all participants
gave GRIP positive ratings, especially those who completed a minimum of 12 sessions.
6.0 Discussion
The purpose of this study was to examine the feasibility and tolerability of GRIP, as well as
to obtain specific treatment parameters (e.g. effect sizes) to inform the implementation of a
larger, more definitive RCT. We hypothesized that GRIP would be well-tolerated and
received, and that it would be associated with a greater reduction in symptoms, improvement
in functioning, and lower hospitalization rates than TAU alone.
Overall, GRIP appears to be a feasible and well-tolerated intervention. Drop-out rates were
low and attendance rates, particularly for treatment “completers” were high. In fact, our
drop-out rates compare favorably to other individual therapy studies for first episode
psychosis (J Edwards et al., 2006; Gleeson et al., 2009; H. Jackson et al., 2005; H. J.
Jackson et al., 2008; Kavanagh et al., 2004; Power et al., 2003; Nick Tarrier et al., 2004). In
addition, feedback from participants was consistently positive (based on their questionnaire
ratings), suggesting that GRIP was meeting their treatment needs. Thus, GRIP appears to be
an acceptable intervention to clients with first episode psychosis.
In regard to the primary and secondary outcomes, the lack of significant effects observed in
the mixed models (with the exception of the work productivity scale on the RFS) might
suggest that GRIP did not add clinical value beyond treatment as usual. However, these
findings may be due to lack of statistical power, since by and large, the results were in the
hypothesized direction and the effect sizes were not insubstantial. And, this was a pilot study
and was not statistically powered to definitively test these hypotheses. Most of the
participants in the RCT (44/46) were clients of the OASIS program, which offers
comprehensive services for clients with first episode psychosis. Thus, it is possible that the
therapeutic effects of a specialty first episode program account for most of the variance in
client improvement, thus setting a high bar for individual therapy to make an impact.
Our secondary analyses examined effect sizes and within-group changes. These analyses
suggest that GRIP might have an impact on functional outcomes, as participants who
received GRIP showed significant within group change through 3-month follow-up on role
functioning (as measured by the RFS) and social competence (as measured by the MCAS),
and trend level improvement in quality of life. These effect sizes were, for the most part,
consistently larger than those observed for participants who received TAU, and were in the
small to medium range. In addition, the GRIP group had higher effect sizes through follow-
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up on the PANSS than the TAU group, but the within group change was not statistically
significant. Although the GRIP group showed an increase in alcohol use from baseline to
follow-up, post-hoc analyses revealed that only treatment non-completers had a significant
increase in alcohol use. This suggests that alcohol use may have a relationship with
treatment engagement and retention. Finally, GRIP participants were hospitalized less
frequently than those who received TAU, although these differences were not statistically
significant. Thus, the pattern of findings seems to favor GRIP over TAU in improving the
functioning of clients with first episode psychosis, and indicate that this treatment may be
worth further investigation
In general, GRIP did not have an effect on social support, beliefs about medications, and
psychological well-being. Interestingly, individuals who received TAU alone did show
unexpected improvement in these areas, particularly social support and beliefs about
medications, as well as a reduction in depression. These findings underscore the potential
effectiveness of multi-element treatment programs for first episode psychosis, but they don’t
explain the lack of an effect for the group that received GRIP. It is possible that a focused
discussion on medication adherence (as done in Phase I of GRIP), may not be effective
approach for individuals with first episode psychosis. In regard to social support, the TAU
group was (non-significantly) lower than the GRIP group at baseline, with only 1.46 points
separating the two groups at 3-month follow-up, so regression to the mean is also a
possibility. The important point, however, is that GRIP did not impact social support, beliefs
about medications, and psychological well-being suggesting that changes need to be made to
the intervention in order to improve its effectiveness in these domains.
The findings also emphasize the importance of treatment engagement for clients with first
episode psychosis. Treatment “completers” tended to be more successful at achieving their
goals relative to “non-completers.” This was true regardless of whether goal attainment was
rated by clients themselves or their clinicians. This is not a trivial issue, as goal attainment is
linked to mental health (King, 2001). Thus, strategies to increase treatment engagement are
potentially critical to improving client’s quality of life and well-being.
This study has a number of strengths and weaknesses which should be acknowledged.
Strengths include a well-developed intervention, clearly differentiated treatment conditions,
utilization of psychometrically sound measures, low drop-out rates, and raters blind to
treatment assignment for the clinical (PANSS, CDSS) and quality of life assessments.
Weaknesses include the small sample size of the pilot RCT, the lack of rater blindness for
two of the functional outcome measures (RFS and MCAS), the short follow-up period, and
measures which may not have been sensitive to change, were not directly linked with the
intervention (e.g. mood; social support), and did not adequately capture recovery from the
client’s perspective.
In closing, the results of this study indicate that GRIP is a feasible intervention for first
episode psychosis and is well-tolerated by clients. Both GRIP and TAU, which was
provided at a comprehensive specialty first episode program, resulted in improvements
across both functional and clinical domains, although evaluation of effect sizes suggest an
advantage for GRIP in improving functional outcomes (which again, need to be interpreted
cautiously in a preliminary study, (Kraemer et al., 2006). Thus, the results of this small scale
RCT suggest that GRIP has promise and that a larger, more definitive clinical trial may be
warranted.
Acknowledgments
The authors would like to thank the clients, clinicians, and researchers who have contributed to the development
and evaluation of GRIP. We also acknowledge the assistance of Abby Scheer for providing data management
Penn et al. Page 10













services, Brent Moos, LCSW and Lyse Debourguignon, LCSW, for serving as GRIP therapists, Jennifer Nieri,
LCSW, Piper Meyer, Ph.D, and Leanne Whaley Owens, B.A. for conducting study assessments, Bebe Smith,
LCSW, Karen Graham, M.D. and Lisa Cooper, for administrative and clinical support at OASIS, and the Duke
Endowment and KB Reynolds Foundations, for providing support for the development of OASIS. Support for the
development and evaluation of GRIP has been provided by NIMH grant R34 1-MH071252-01A1 awarded to DLP.
References
Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: The Calgary
Depression Scale. British Journal of Psychiatry 1993;163 Suppl 22:39–44.
Addington J, Gleeson J. Implementing cognitive-behavioural therapy for first-episode psychosis.
British Journal of Psychiatry 2005;187 suppl. 48:s72–s76.
Birchwood M, Todd P, Jackson C. Early intervention in psychosis: The critical period hypothesis.
British Journal of Psychiatry 1998;172 Suppl. 33:53–59. [PubMed: 9534833]
Dickerson FB, Origoni AE, Pater A, Friedman BK, Kordonski WM. An expanded version of the
Multnomah Community Ability Scale: Anchors and interview probes for the assessment of adults
with serious mental illness. Community Mental Health Journal 2003;39(2):131–137. [PubMed:
12723847]
Dolder CR, Lacro JP, Warren KA, Golshan S, Perkins DO, Jeste DV. Brief Evaluation of Medication
Influences and Beliefs: Development and Testing of a Brief Scale for Medication Adherence.
Journal of Clinical Psychopharmacology 2004;24(4):404–409. [PubMed: 15232332]
Drake, RE.; Mueser, KT.; McHugo, GJ. Clinician rating scales: Alcohol Use Scale (AUS), Drug Use
Scale (DUS), and Substance Abuse Treatment Scale (SATS). In: Sederer, LI.; Dickey, B., editors.
Outcomes assessment in clinical practice. Baltimore: Williams & Wilkins; 1996. p. 113-116.
Edwards J, Elkins K, Hinton M, Harrigan S, Donovan K, Athanasopoulos O, et al. Randomized
controlled trial of a cannabis-focused intervention for young people with first-episode psychosis.
Acta Psychiatric Scandinavica 2006;114(2)
Edwards, J.; Hinton, M.; Elkins, K.; Anthanasopoulos, O. Cannabis and first-episode psychosis: The
CAP project. In: Graham, H.; Mueser, KT.; Birchwood, M.; Copello, A., editors. Substance misuse
in psychosis: Approaches to treatment and service delivery. Chichester: John Wiley & Sons; 2003.
p. 283-304.
Fowler D, Hodgekins J, Painter M, Reilly T, Crane C, Macmillan I, et al. Cognitive behaviour therapy
for improving social recovery in psychosis: a report from the ISREP MRC Trial Platform study
(Improving Social Recovery in Early Psychosis). Psychological Medicine 2009;39(10):1627–1636.
[PubMed: 19335932]
Gleeson JFM, Cotton SM, Alvarez-Jimenez M, Wade D, Gee D, Crisp K, et al. A randomized
controlled trial of relapse prevention therapy for first-episode psychosis patients. Journal of
Clinical Psychiatry 2009;70(4):477–486. [PubMed: 19323964]
Goodman SH, Sewell DR, Cooley EL, Leavitt N. Assessing levels of adaptive functioning: The Role
Functioning Scale. Community Mental Health Journal 1993;29(2):119–131. [PubMed: 8500285]
Haddock G, Lewis S. Psychological Interventions in Early Psychosis. Schizophrenia Bulletin
2005;31(3):697–704. [PubMed: 16006594]
Harvey P-O, Lepage M, Malla A. Benefits of enriched intervention compared with standard care for
patients with recent-onset psychosis: a metaanalytic approach. Canadian Journal of Psychiatry
2007;52:464–472.
Heinrichs DW, Hanlon TE, Carpenter WT. The Quality of Life Scale: An instrument for rating the
schizophrenic deficit syndrome. Schizophrenia Bulletin 1984;10(3):388–398. [PubMed: 6474101]
Jackson C, Trower P, Reid I, Smith J, Hall M, Townend M, et al. Improving psychological adjustment
following a first episode of psychosis: a randomized controlled trial of cognitive therapy to reduce
post psychotic trauma symptoms. Behaviour Research and Therapy 2009;47:454–462. [PubMed:
19361782]
Jackson H, McGorry P, Edwards J, Hulbert C, Henry L, Harrigan S, et al. A controlled trial of
cognitively oriented psychotherapy for early psychosis (COPE) with four-year hollow-up
readmission data. Psychological Medicine 2005;35:1–12.
Penn et al. Page 11













Jackson HJ, McGorry PD, Killackey E, Bendall S, Allott K, Dudgeon P, et al. Acute phase and 1-year
follow-up results of a randomized controlled trial of CBT versus befriending for first-episode
psychosis: The ACE project. Psychological Medicine 2008;38(5):725–735. [PubMed: 18005494]
Kavanagh DJ, Young R, White A, Saunders JB, Wallis J, Shockley N, et al. A brief motivational
intervention for substance misuse in recent-onset psychosis. Drug and Alcohol Review
2004;23:151–155. [PubMed: 15370020]
Kay SR, Opler LA, Lindenmayer J-P. Reliability and validity of the Positive and Negative Syndrome
Scale for schizophrenics. Psychiatry Research 1988;23(1):99–110. [PubMed: 3363019]
Kenward MG, Roger JH. Small Sample Inference for Fixed Effects from Restricted Maximum
Likelihood. Biometrics 1997;53(3):983–997. [PubMed: 9333350]
King LA. The health benefits of writing about life goals. Personality and Social Psychology Bulletin
2001;27(7):798–807.
Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA. Caution Regarding the Use of Pilot
Studies to Guide Power Calculations for Study Proposals. Archives of General Psychiatry
2006;63(5):484–489. [PubMed: 16651505]
Lecomte T, Leclerc C, Corbière M, Wykes T, Wallace CJ, Spidel A. Group cognitive behavior therapy
or social skills training for individuals with a recent onset of psychosis? Results of a randomized
controlled trial. Journal of Nervous and Mental Disease 2008;196(12):866–875. [PubMed:
19077853]
Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, et al. Randomised controlled
trial of cognitive-behavioural therapy in early schizophrenia: Acute-phase outcomes. British
Journal of Psychiatry 2002;181 Suppl. 43:s91–s97.
Malla AK, Norman RM, Joober R. First-episode psychosis, early intervention, and outcome: What
have we learned? Canadian Journal of Psychiatry 2005;50(14):881–891.
Mueser, KT.; Drake, RE. How Does a Practice Become Evidence-Based?. In: Drake, RE.; Merrens,
MR.; Lynde, DW., editors. Evidence-based mental health practice: A textbook. New York, NY
US: W W Norton & Co; 2005. p. 217-241.
Patterson TL, Moscona S, McKibbin CL, Davidson K, Jeste DV. Social skills performance assessment
among older patients with schizophrenia. Schizophrenia Research 2001;48(2–3):351–360.
[PubMed: 11295387]
Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA. Psychosocial treatment for first-
episode psychosis: A research update. American Journal of Psychiatry 2005;162:2220–2232.
[PubMed: 16330584]
Power P, Bell RJ, Mills R, Herrman-Doig T, Davern M, Henry L, et al. Suicide prevention in first
episode psychosis: The development of a randomised controlled trial of cognitive therapy for
acutely suicidal patients with early psychosis. Australian and New Zealand Journal of Psychiatry
2003;37:414–420. [PubMed: 12873325]
Ryff CD. Happiness is everything, or is it? Explorations on the meaning of psychological well-being.
Journal of Personality and Social Psychology 1989;57(6):1069–1081.
Saksa JR, Cohen SJ, Srihari VH, Woods SW. Cognitive behavior therapy for early psychosis: A
comprehensive review of individual vs. group treatment studies. International Journal of Group
Psychotherapy 2009;59(3):357–383. [PubMed: 19548785]
Tarrier N, Haddock G, Lewis S, Drake R, Gregg L. Suicide behaviour over 18 months in recent onset
schizophrenic patients: The effects of CBT. Schizophrenia Research 2006;83:15–27. [PubMed:
16460916]
Tarrier N, Lewis S, Haddock G, Bentall R, Drake R, Kinderman P, et al. Cognitive-behavioural
therapy in first-episode and early schizophrenia: 18-month follow-up of a randomised controlled
trial. British Journal of Psychiatry 2004;184(3):231–239. [PubMed: 14990521]
Tauber R, Wallace CJ, Lecomte T. Enlisting indigenous community supporters in skills training
programs for persons with severe mental illness. Psychiatric Services 2000;51(11):1428–1432.
[PubMed: 11058191]
The Psychological Corporation. Manual for the Wechsler Abbreviated Scale of Intelligence. San
Antonio, TX: The Psychological Corporation; 1999.
Penn et al. Page 12













Uzenoff SR, Perkins DO, Hamer RM, Wiesen CA, Penn DL. A preliminary trial of adherence-coping-
education (ACE) therapy for early psychosis. Journal of Nervous and Mental Disease 2008;196(7):
572–575. correction, 196(510), 780. [PubMed: 18626299]
Waldheter EJ, Penn DL, Perkins DO, Mueser KT, Owens LW, Cook E. The Graduated Recovery
Intervention Program for first episode psychosis: treatment development and preliminary data.
Community Mental Health Journal. 2008 May 31 Epub ahead of print.
Zimet GD, Powell SS, Farley GK, Werkman S. Psychometric characteristics of the Multidimensional
Scale of Perceived Social Support. Journal of Personality Assessment 1990;55(3–4):610–617.
[PubMed: 2280326]
Penn et al. Page 13














GRIP RCT Consort Diagram
Penn et al. Page 14



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Schizophr Res. Author manuscript; available in PMC 2012 February 1.
